Picture this: Your doctor orders an imaging test like a chest X-ray in preparation for an upcoming procedure, and the results show a small white spot in the center of your lungs—a pulmonary or lung ...
The genomic test is designed to limit invasive procedures for low-risk patients with suspicious lung nodules. Veracyte, Inc, announced last week that its Percepta test, the first product under a ...
Please provide your email address to receive an email when new articles are posted on . A risk-assessment test that combined levels of plasma proteins and clinical factors accurately determined ...
New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the ...
Midland Daily News on MSN
MyMichigan Health: Lung nodules don’t necessarily mean cancer
Lung nodules are clusters of cells found during an x-ray or CT scan that appear as more dense or white spots in the lungs.
Veracyte Announces New Expanded Data at CHEST Underscoring Percepta Nasal Swab Test’s Ability to Improve Early Lung Cancer Assessment Company begins making novel, noninvasive test available to limited ...
EverythingLubbock.com on MSN
Covenant Health launches Lung Nodule Clinic for early lung cancer detection
The service ensures patients are scheduled to visit the clinic within a week of lung nodule detection in those with the ...
BOULDER, Colo.--(BUSINESS WIRE)-- Biodesix, Inc. (Nasdaq: BDSX) a leading data-driven diagnostic solutions company with a focus in lung disease, today announced publication of an analysis of the ...
Non-invasive genomic test is designed to help physicians guide next steps for current and former smokers with lung nodules Lung cancer is the leading cause of cancer death worldwide. Lung nodules are ...
A U.S.-based diagnostics company is expanding its presence in lung cancer with the acquisition of assets from a firm based in the U.K. Boulder, Colorado-based Biodesix said Friday that it would buy ...
In a recent study published in the Radiology, researchers performed a single-center, open-label randomized controlled trial (RCT) to investigate whether commercial artificial intelligence (AI)-debased ...
BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX) a leading data-driven diagnostic solutions company with a focus in lung disease, today announced publication of an analysis of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results